Total Valuation
Kwang Dong Pharmaceutical Co., Ltd. has a market cap or net worth of ₩278.48B. The enterprise value is ―.
Market Cap₩278.48B
Enterprise Value―
Share Statistics
Kwang Dong Pharmaceutical Co., Ltd. has 49,799,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding49,799,810
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kwang Dong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.07%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.07%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee1.60B
Profits Per Employee20.16M
Employee Count1,040
Asset Turnover1.26
Inventory Turnover6.71
Valuation Ratios
The current PE Ratio of Kwang Dong Pharmaceutical Co., Ltd. is 11.5. Kwang Dong Pharmaceutical Co., Ltd.’s PEG ratio is -0.23.
PE Ratio11.5
PS Ratio0.19
PB Ratio0.47
Price to Fair Value0.47
Price to FCF5.38
Price to Operating Cash Flow5.63
PEG Ratio-0.23
Income Statement
In the last 12 months, Kwang Dong Pharmaceutical Co., Ltd. had revenue of 1.66T and earned 20.97B in profits. Earnings per share was 521.00.
Revenue1.66T
Gross Profit293.22B
Operating Income31.05B
Pretax Income30.98B
Net Income20.97B
EBITDA48.54B
Earnings Per Share (EPS)521.00
Cash Flow
In the last 12 months, operating cash flow was 52.23B and capital expenditures -19.01B, giving a free cash flow of 33.21B billion.
Operating Cash Flow52.23B
Free Cash Flow33.21B
Free Cash Flow per Share666.91
Dividends & Yields
Kwang Dong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-10.04%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)209.02K
Important Dates
Kwang Dong Pharmaceutical Co., Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Kwang Dong Pharmaceutical Co., Ltd. as a current ratio of 1.36, with Debt / Equity ratio of 46.58%
Current Ratio1.36
Quick Ratio0.98
Debt to Market Cap0.93
Net Debt to EBITDA3.34
Interest Coverage Ratio2.82
Taxes
In the past 12 months, Kwang Dong Pharmaceutical Co., Ltd. has paid 9.65B in taxes.
Income Tax9.65B
Effective Tax Rate0.31
Enterprise Valuation
Kwang Dong Pharmaceutical Co., Ltd. EV to EBITDA ratio is 9.67, with an EV/FCF ratio of 8.22.
EV to Sales0.28
EV to EBITDA9.67
EV to Free Cash Flow8.22
EV to Operating Cash Flow5.70
Balance Sheet
Kwang Dong Pharmaceutical Co., Ltd. has ₩182.71B in cash and marketable securities with ₩301.19B in debt, giving a net cash position of -₩118.48B billion.
Cash & Marketable Securities₩182.71B
Total Debt₩301.19B
Net Cash-₩118.48B
Net Cash Per Share-₩2.38K
Tangible Book Value Per Share₩12.70K
Margins
Gross margin is 17.65%, with operating margin of 1.87%, and net profit margin of 1.26%.
Gross Margin17.65%
Operating Margin1.87%
Pretax Margin1.87%
Net Profit Margin1.26%
EBITDA Margin2.92%
EBIT Margin1.87%
Analyst Forecast
The average price target for Kwang Dong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.41%
EPS Growth Forecast-21.19%